Evidence map›Paper›PMID 37829173›Full record

ArticleJSLS : Journal of the Society of Laparoendoscopic Surgeons

Effectiveness and Cost of Stenting in Ureteral Injury in Colorectal Surgeries in the US: 2015 - 2019.

Ana Filipa Alexandre, Tomomi Kimura, Qi Feng, Wei Han, Emily Shortridge, Jason Schwartz, Steven D Wexner

Open access · bronzeAbstract read
In one paragraph

Article in JSLS : Journal of the Society of Laparoendoscopic Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ana Filipa AlexandreHealth Economics Outcomes Research, Astellas Pharma Europe B.V., Leiden, The Netherlands. (Dr. Alexandre was Astellas employee at time of study).
Tomomi KimuraGlobal Development, Astellas Pharma US, Inc., Northbrook, IL. (Drs. Kimura, Feng, Han, Shortridge, Schwartz).
Qi FengGlobal Development, Astellas Pharma US, Inc., Northbrook, IL. (Drs. Kimura, Feng, Han, Shortridge, Schwartz).
Wei HanGlobal Development, Astellas Pharma US, Inc., Northbrook, IL. (Drs. Kimura, Feng, Han, Shortridge, Schwartz).
Emily ShortridgeGlobal Development, Astellas Pharma US, Inc., Northbrook, IL. (Drs. Kimura, Feng, Han, Shortridge, Schwartz).
Jason SchwartzGlobal Development, Astellas Pharma US, Inc., Northbrook, IL. (Drs. Kimura, Feng, Han, Shortridge, Schwartz).
Steven D WexnerColorectal Surgery, Cleveland Clinic Florida, Weston, FL. (Dr. Wexner).
Astellas Pharma (United States) · USAstellas Pharma (Netherlands) · NLCleveland Clinic Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intraoperative ureteral injury (IUI) during colorectal surgery can have devastating consequences. This study aimed to assess the clinical and economic impact of pre-operative ureteral stenting in colorectal surgeries. Methods: A retrospective cohort study was conducted using United States hospital data (October 2015 - December 2019). IUI incidence was examined across selected inpatient surgery types (elective colectomy, enterectomy, proctectomy, enterostomy, other colorectal procedures; emergency colectomy). Stenting effectiveness was evaluated as the difference in IUI and intraoperative detection rates between propensity score-matched groups. The additional hospital cost for stenting was also estimated considering the savings from IUIs that were potentially avoidable or detected by stenting. Results: In total, 283,549 colorectal surgeries were analyzed. Across surgery types, stent use and IUI incidence ranged from 1.47% - 8.86% and from 0.91% - 2.90%, respectively. Stents were used in 6.75% of elective colectomy cases, where they were associated with an absolute reduction of 1.14 percentage points (95% CI: -1.85 to -1.03) in IUI rate and a 21.6 percentage point reduction in the intraoperative detection rate. Additional hospital costs for stenting ranged from $1,464 - $4,436 across surgery types. Additional results varied by case but were consistent with the colectomy example. Conclusions: While effective in limited settings, the IUI reduction attributed to stenting and ability to shift IUI detection to the intraoperative setting could not offset the hospital cost of stent placement during colectomy (and colorectal surgery, in general). There thus remains an ongoing need in colorectal surgery for a universal, cost-effective solution to prevent IUI.

Indexed as

Colorectal NeoplasmsUreterAnastomosis, SurgicalColectomyHumansRetrospective StudiesStentsColectomyColorectal surgeryEconomic impactIntraoperative ureteral injuryPre-operative ureteral catheterization or stenting

Identifiers

PMID37829173
PMCPMC10566578
OpenAlexW4387573523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.